Evidence map›Paper›PMID 36269767›Full record

ArticlePloS one2022

Virological suppression among gay, bisexual, and other men who have sex with men living with HIV in Vancouver, Canada: A longitudinal cohort study from 2012-2017.

Heather L Armstrong, Julian Gitelman, Zishan Cui, Nicanor Bacani, Paul Sereda, Nathan J Lachowsky, Kiffer G Card, Jordan M Sang, Henry F Raymond, Julio Montaner and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Heather L ArmstrongBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.ORCID 0000-0002-1071-8644
Julian GitelmanFaculty of Medicine, University of Toronto, Toronto, Canada.
Zishan CuiBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Nicanor BacaniBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Paul SeredaBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.ORCID 0000-0002-6411-8089
Nathan J LachowskyBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Kiffer G CardBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Jordan M SangBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.ORCID 0000-0001-5649-0326
Henry F RaymondSchool of Public Health, Rutgers University, Piscataway, New Jersey, United States of America.
Julio MontanerBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
David HallImmunodeficiency Clinic, St. Paul's Hospital, Vancouver, Canada.
Terry HowardMomentum Health Study, Community Advisory Board, Vancouver, Canada.
Mark HullBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Robert S HoggBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Eric A RothBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
David M MooreBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
AIDS Vancouver · CAUniversity of British Columbia · CAUniversity of Victoria · CAConference Board of Canada · CARutgers, The State University of New Jersey · USSimon Fraser University · CASt. Paul's Hospital · CAUniversity of Toronto · CA

Funding

Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BCR01DA036307 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ · 2013 to 2017
$3.0M
HAART optimism, drug use and risky sexual behavior among MSM in British Columbia.R01DA031055 · NIDA · SIMON FRASER UNIVERSITY · PI HOGG, ROBERT S · 2011 to 2015
$2.0M
CIHR FDN-143342CIHR MFE-152443CIHR MOP-107544CIHR PJT-153139NIDA NIH HHS R01 DA031055NIDA NIH HHS R01 DA036307
6 · The paper itself

Abstract

introductionIn 2010, British Columbia (BC) implemented HIV Treatment as Prevention (TasP) as policy. We examined trends in virologic suppression and determinants of significant viremia among a prospective biobehavioural cohort of men who have sex with men (gbMSM) in Vancouver from 2012-2017.

methodsRespondent-driven sampling was used to recruit sexually active gbMSM (≥16 years) who completed biannual study visits with a computer-assisted self-interview and clinical CD4 and viral load (VL) testing. We linked participant data with the BC HIV Drug Treatment Program to obtain antiretroviral dispensing and VL data. We conducted a trend analysis of VL suppression using univariable generalized estimating equation (GEE) multi-level modelling and multivariable GEE to identify factors associated with episodes of VL ≥200 copies/mL.

resultsOf 774 participants, 223 were living with HIV at baseline and 16 were diagnosed during follow-up (n = 239). We observed a significant trend towards reduced levels of unsuppressed VL (>200 copies/mL) from 22% (07/2012-12/2012) to 12% (07/2016-12/2016) (OR:0.87; 95%CI:0.83-0.91 for each 6-month period). Among those with at least one follow-up visit, (n = 178, median follow-up = 3.2 years, median age = 46.9 years), younger age (aOR:0.97; 95%CI:0.94-0.99, per year), ecstasy use (aOR:1.69; 95%CI:1.13-2.53), crystal methamphetamine use (aOR:1.71; 95%CI:1.18-2.48), seeking sex via websites (aOR:1.46; 95%CI:1.01-2.12), and lower HIV treatment optimism (aOR:0.94; 95%CI:0.90-0.97) were associated with episodes of elevated viremia.

conclusionsDuring a period when TasP policy was actively promoted, we observed a significant trend towards reduced levels of unsuppressed VL. Continued efforts should promote HIV treatment optimism and engagement, especially among younger gbMSM and those who use ecstasy and crystal methamphetamine.

Indexed as

HIV InfectionsMethamphetamineSexual and Gender MinoritiesBritish ColumbiaCanadaCohort StudiesHomosexuality, MaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesViral LoadViremiaMethamphetamine

Identifiers

PMID36269767
PMCPMC9586352
OpenAlexW4307002317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.